110 related articles for article (PubMed ID: 9422087)
1. 'Epitope fingerprinting' using overlapping 20-mer peptides of the MUC1 tandem repeat sequence.
Schol DJ; Meulenbroek MF; Snijdewint FG; von Mensdorff-Pouilly S; Verstraeten RA; Murakami F; Kenemans P; Hilgers J
Tumour Biol; 1998; 19 Suppl 1():35-45. PubMed ID: 9422087
[TBL] [Abstract][Full Text] [Related]
2. Epitope characterization of MUC1 antibodies.
Blockzjil A; Nilsson K; Nilsson O
Tumour Biol; 1998; 19 Suppl 1():46-56. PubMed ID: 9422088
[TBL] [Abstract][Full Text] [Related]
3. Epitope characterization of MUC1 antibodies.
Imai S; Haga S; Kiyozuka Y
Tumour Biol; 1998; 19 Suppl 1():30-4. PubMed ID: 9422086
[TBL] [Abstract][Full Text] [Related]
4. Epitope mapping of anti-MUC1 mucin protein core monoclonal antibodies.
Petrakou E; Murray A; Price MR
Tumour Biol; 1998; 19 Suppl 1():21-9. PubMed ID: 9422085
[TBL] [Abstract][Full Text] [Related]
5. Characterization of a new MUC1 monoclonal antibody (VU-2-G7) directed to the glycosylated PDTR sequence of MUC1.
Ryuko K; Schol DJ; Snijdewint FG; von Mensdorff-Pouilly S; Poort-Keesom RJ; Karuntu-Wanamarta YA; Verstraeten RA; Miyazaki K; Kenemans P; Hilgers J
Tumour Biol; 2000; 21(4):197-210. PubMed ID: 10867613
[TBL] [Abstract][Full Text] [Related]
6. Summary report on the ISOBM TD-4 Workshop: analysis of 56 monoclonal antibodies against the MUC1 mucin. San Diego, Calif., November 17-23, 1996.
Price MR; Rye PD; Petrakou E; Murray A; Brady K; Imai S; Haga S; Kiyozuka Y; Schol D; Meulenbroek MF; Snijdewint FG; von Mensdorff-Pouilly S; Verstraeten RA; Kenemans P; Blockzjil A; Nilsson K; Nilsson O; Reddish M; Suresh MR; Koganty RR; Fortier S; Baronic L; Berg A; Longenecker MB; Hilgers J
Tumour Biol; 1998; 19 Suppl 1():1-20. PubMed ID: 9422084
[TBL] [Abstract][Full Text] [Related]
7. Specificity clusters of MUC1-reactive mouse monoclonal antibodies.
Hanisch FG
Tumour Biol; 1998; 19 Suppl 1():111-7. PubMed ID: 9422095
[TBL] [Abstract][Full Text] [Related]
8. Carcinoma-associated MUC1 detected by immunoradiometric assays.
Norum LF; Varaas T; Kierulf B; Nustad K
Tumour Biol; 1998; 19 Suppl 1():134-46. PubMed ID: 9422099
[TBL] [Abstract][Full Text] [Related]
9. Identification of a novel cancer-specific immunodominant glycopeptide epitope in the MUC1 tandem repeat.
Tarp MA; Sørensen AL; Mandel U; Paulsen H; Burchell J; Taylor-Papadimitriou J; Clausen H
Glycobiology; 2007 Feb; 17(2):197-209. PubMed ID: 17050588
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and antibody recognition of synthetic antigens from MUC1.
Bánóczi Z; Mezõ G; Windberg E; Uray K; Majer Z; Hudecz F
J Pept Sci; 2008 May; 14(5):610-6. PubMed ID: 17975847
[TBL] [Abstract][Full Text] [Related]
11. A straightforward protocol for the preparation of high performance microarray displaying synthetic MUC1 glycopeptides.
Matsushita T; Takada W; Igarashi K; Naruchi K; Miyoshi R; Garcia-Martin F; Amano M; Hinou H; Nishimura S
Biochim Biophys Acta; 2014 Mar; 1840(3):1105-16. PubMed ID: 24246952
[TBL] [Abstract][Full Text] [Related]
12. Characterization of a panel of monoclonal antibodies using GalNAc glycosylated peptides and recombinant MUC1.
Reis CA; Hassan H; Bennett EP; Clausen H
Tumour Biol; 1998; 19 Suppl 1():127-33. PubMed ID: 9422098
[TBL] [Abstract][Full Text] [Related]
13. Epitope mapping of antigenic MUC1 peptides to breast cancer antibody fragment B27.29: a heteronuclear NMR study.
Grinstead JS; Schuman JT; Campbell AP
Biochemistry; 2003 Dec; 42(48):14293-305. PubMed ID: 14640698
[TBL] [Abstract][Full Text] [Related]
14. Discrimination of MUC1 mucins from other sialyl-Le(a)-carrying glycoproteins produced by colon carcinoma cells using a novel monoclonal antibody.
Baeckström D; Nilsson O; Price MR; Lindholm L; Hansson GC
Cancer Res; 1993 Feb; 53(4):755-61. PubMed ID: 7679050
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Pepscan analyses for epitope mapping of anti-MUC1 monoclonal antibodies--a comparative study and review of five antibodies.
Petrakou E; Murray A; Rosamund C; Graves L; Price MR
Anticancer Res; 1998; 18(6A):4419-21. PubMed ID: 9891503
[TBL] [Abstract][Full Text] [Related]
16. Human single-chain Fv antibodies to MUC1 core peptide selected from phage display libraries recognize unique epitopes and predominantly bind adenocarcinoma.
Henderikx P; Kandilogiannaki M; Petrarca C; von Mensdorff-Pouilly S; Hilgers JH; Krambovitis E; Arends JW; Hoogenboom HR
Cancer Res; 1998 Oct; 58(19):4324-32. PubMed ID: 9766660
[TBL] [Abstract][Full Text] [Related]
17. Characterization of an anti-MUC1 monoclonal antibody with potential as a cancer vaccine.
Qi W; Schultes BC; Liu D; Kuzma M; Decker W; Madiyalakan R
Hybrid Hybridomics; 2001; 20(5-6):313-24. PubMed ID: 11839249
[TBL] [Abstract][Full Text] [Related]
18. Reactivity of natural and induced human antibodies to MUC1 mucin with MUC1 peptides and n-acetylgalactosamine (GalNAc) peptides.
von Mensdorff-Pouilly S; Petrakou E; Kenemans P; van Uffelen K; Verstraeten AA; Snijdewint FG; van Kamp GJ; Schol DJ; Reis CA; Price MR; Livingston PO; Hilgers J
Int J Cancer; 2000 Jun; 86(5):702-12. PubMed ID: 10797294
[TBL] [Abstract][Full Text] [Related]
19. Enhanced binding of antibodies to the DTR motif of MUC1 tandem repeat peptide is mediated by site-specific glycosylation.
Karsten U; Diotel C; Klich G; Paulsen H; Goletz S; Müller S; Hanisch FG
Cancer Res; 1998 Jun; 58(12):2541-9. PubMed ID: 9635576
[TBL] [Abstract][Full Text] [Related]
20. Effect of desialylation on binding, affinity, and specificity of 56 monoclonal antibodies against MUC1 mucin.
Dai J; Allard WJ; Davis G; Yeung KK
Tumour Biol; 1998; 19 Suppl 1():100-10. PubMed ID: 9422094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
